ARCHIVES

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

This article is from The Cancer Letter archive.

Vol. 38 No. 08 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

House Launches Probe of NCI Spending On Cancer Communications, Education

April 12, 2013

Community Centers Group Lines Up A Speaker

January 10, 1975

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

NCAB Approves Funding for New Construction At Georgetown, Yale

June 3, 1977

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

HCFA Abadons Plan To Cut Cancer Drug Payments.

September 15, 2000